Picard Medical, Inc. (PMI) Form 8-K — Oct 23, 2026
Picard Medical entered into a Warrant Amendment and Exchange Agreement on October 20, 2026 with the placement agent of its December 2025 private placement. Under the deal, all warrants — exercisable for 8,187,766 pre-split shares — were surrendered in exchange for 200,000 post-reverse-split shares of common stock, with no cash consideration either way. The 200,000 Exchange Shares were issued on October 22, 2026 under a Section 3(a)(9) registration exemption. Upon issuance, the warrants were cancelled and terminated, including all anti-dilution and price-protection adjustment rights.
Key figures
- Shares Offered
- 200000
- Reverse split ratio
- 1:50
- Private placement close
- 2025-12-26
- Warrant shares pre split
- 8187766
- Reverse split effective date
- 2026-07-31
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.